Targeting metabolic dysregulation for fibrosis therapy
Fibrosis is the abnormal deposition of extracellular matrix, which can lead to organ
dysfunction, morbidity, and death. The disease burden caused by fibrosis is substantial, and …
dysfunction, morbidity, and death. The disease burden caused by fibrosis is substantial, and …
How macrophages deal with death
G Lemke - Nature Reviews Immunology, 2019 - nature.com
Tissue macrophages rapidly recognize and engulf apoptotic cells. These events require the
display of so-called eat-me signals on the apoptotic cell surface, the most fundamental of …
display of so-called eat-me signals on the apoptotic cell surface, the most fundamental of …
Cell death and immunity in cancer: from danger signals to mimicry of pathogen defense responses
AD Garg, P Agostinis - Immunological reviews, 2017 - Wiley Online Library
The immunogenicity of cancer cells is an emerging determinant of anti‐cancer
immunotherapy. Beyond developing immunostimulatory regimens like dendritic cell‐based …
immunotherapy. Beyond developing immunostimulatory regimens like dendritic cell‐based …
More than suppression: glucocorticoid action on monocytes and macrophages
JM Ehrchen, J Roth, K Barczyk-Kahlert - Frontiers in immunology, 2019 - frontiersin.org
Uncontrolled inflammation is a leading cause of many clinically relevant diseases. Current
therapeutic strategies focus mainly on immunosuppression rather than on the mechanisms …
therapeutic strategies focus mainly on immunosuppression rather than on the mechanisms …
Clearance deficiency and cell death pathways: a model for the pathogenesis of SLE
A Mahajan, M Herrmann, LE Muñoz - Frontiers in immunology, 2016 - frontiersin.org
Alterations of cell death pathways, including apoptosis and the neutrophil specific kind of
death called NETosis, can represent a potential source of autoantigens. Defects in the …
death called NETosis, can represent a potential source of autoantigens. Defects in the …
Apoptotic cell recognition receptors and scavenger receptors
KK Penberthy, KS Ravichandran - Immunological reviews, 2016 - Wiley Online Library
Phosphatidylserine recognition receptors are a highly diverse set of receptors grouped by
their ability to recognize the 'eat‐me'signal phosphatidylserine on apoptotic cells. Most of the …
their ability to recognize the 'eat‐me'signal phosphatidylserine on apoptotic cells. Most of the …
Priming anti-tumor immunity by radiotherapy: dying tumor cell-derived DAMPs trigger endothelial cell activation and recruitment of myeloid cells
J Krombach, R Hennel, N Brix, M Orth, U Schoetz… - …, 2019 - Taylor & Francis
The major goal of radiotherapy is the induction of tumor cell death. Additionally, radiotherapy
can function as in situ cancer vaccination by exposing tumor antigens and providing …
can function as in situ cancer vaccination by exposing tumor antigens and providing …
Novel mechanisms of exosome-mediated phagocytosis of dead cells in injured heart
Rationale: After myocardial ischemic injury, improper phagocytic clearance of dying cardiac
cells and the ensuing lack of inflammation resolution results in adverse cardiac remodeling …
cells and the ensuing lack of inflammation resolution results in adverse cardiac remodeling …
Small extracellular vesicles derived from interferon-γ pre-conditioned mesenchymal stromal cells effectively treat liver fibrosis
S Takeuchi, A Tsuchiya, T Iwasawa, S Nojiri… - NPJ Regenerative …, 2021 - nature.com
Mesenchymal stromal cells (MSCs) are used for ameliorating liver fibrosis and aiding liver
regeneration after cirrhosis; Here, we analyzed the therapeutic potential of small …
regeneration after cirrhosis; Here, we analyzed the therapeutic potential of small …
Fighting the fire: mechanisms of inflammatory gene regulation by the glucocorticoid receptor
L Escoter-Torres, G Caratti, A Mechtidou… - Frontiers in …, 2019 - frontiersin.org
For many decades, glucocorticoids have been widely used as the gold standard treatment
for inflammatory conditions. Unfortunately, their clinical use is limited by severe adverse …
for inflammatory conditions. Unfortunately, their clinical use is limited by severe adverse …